Pfizer, BioNTech enter $3.2bn deal with US government for Covid-19 shots
Pharmaceutical Technology
JUNE 30, 2022
Pfizer and BioNTech have entered a new vaccine supply agreement worth $3.2bn with the US government to supply further doses of their Covid-19 vaccine. As per the agreement, the government will procure 105 million 3µg, 10 µg and 30 µg doses of the vaccine.
Let's personalize your content